Instructor Notes — Chapter 26

Part 5 · advanced · prerequisites Ch 5, Ch 25, Ch 1 Suggested time: two 75-minute sessions, or one 3-hour seminar. This chapter does not compress well into a single lecture hour; if that is all you have, teach §26.1–§26.3 and assign the rest.

Before you teach this

Find out who is in the room. In any group of adults, some proportion has a personal connection to cancer treatment — their own or a family member's. You will not know who. Teach as though at least one person is holding this material against a real diagnosis, because in most rooms that is true.

Practically, this means three things. Do not use the word "cure" in your own voice. Do not open with a recruiting-poster framing ("imagine a vaccine that eliminates cancer") — the chapter is deliberately built to dismantle that framing, and starting with it costs you credibility with exactly the students who most need the chapter. And when a student asks whether they or a relative should seek out a trial, do not answer the clinical question. Redirect to the treating oncologist and say plainly that you are not in a position to advise. That refusal is a teachable moment, not an evasion.

Be honest that you may be teaching stale material. Between writing and teaching, a confirmatory trial may have reported. Check before class. If something has moved, teach the movement — a rating changing in real time is a better lesson than any static content in this chapter.

What this chapter is actually for

Students arrive expecting the chapter to be about cancer vaccines. It is not, primarily. It is about a category error that this book has been building toward since Chapter 1: the assumption that knowing how something works tells you whether it helps.

Chapter 26 is the cleanest available demonstration because the mechanism is completely settled — a ✅ so solid it earned a Nobel Prize — and the clinical claim built on it is 🔬. Nowhere else in the book is the gap between mechanistic certainty and clinical uncertainty this wide or this well documented.

If your students leave with one thing, it should be that gap, not the pipeline diagram.

The three hard concepts, in teaching order

1. A vaccine's effect is not occupancy. Students who have absorbed Chapters 3 and 33 will instinctively ask about half-life, and the question is a trap they set for themselves. The occupancy vs instruction diagram in §26.1 is the fix. Spend real time here; everything downstream is easier if the unit of effect is properly reset.

2. Presentation is a filter, and it is personal. The counterintuitive move is that a peptide vaccine can fail in a person not weakly but totally, because the mechanism never engaged. Students routinely translate "no response" into "weak immune system." Quiz item 8 is built specifically to catch this; consider using it as a warm-up rather than an assessment.

3. Tolerance explains thirty years of failure. This is the intellectual payoff and it lands hardest if you set it up as a puzzle before revealing it: why would vaccinating against a protein a tumor overexpresses not work, given that the vaccines demonstrably raised T-cell responses? Let them struggle for a few minutes. The answer — that the response being raised was drawn from a repertoire purged of exactly the useful clones — reframes the whole history.

Where students go wrong

• Conflating the immune readout with the clinical endpoint. This is the single most common error and it is not a novice error — it appears in published abstracts. Drill it. Case study 26.2 exists for this purpose.
• Treating 🔬 as a polite ❌. It is not. 🔬 means "proceeding properly, unproven," and the chapter is explicit that individualized neoantigen vaccines may well move up.
• Treating 🔬 as a polite ⚠️. Also wrong, in the other direction. §26.10 adjudicates the boundary in five numbered points; make students reproduce them.
• Assuming personalization implies efficacy. "It's made from their own tumor, so of course it works" is intuitively powerful and completely unfounded. Discussion question 6 of case study 26.1 targets it directly.
• Reading the ❌-to-⚠️ historical rating as a verdict on neoantigens. The §26.8 scope warning exists because this error is nearly universal on first reading.
• Believing mRNA vaccines are "not peptides, so not in this book." §26.6 handles it; make sure they can state the distinction in one sentence.

Assessment guidance

The exercises are set A–F, 34 items, with 10 marked †. A reasonable problem set is one item from each set plus two † items. Sets D and E carry the chapter's load; sets A–C are foundation and F is communication.

The quiz (22 items) is calibrated so that a student who read carefully should score high on 1–14 and find 15–22 discriminating. Item 19 is the best single predictor of whether a student understood the chapter — it tests the responder/non-responder confound, which cannot be answered from memory.

For a written assignment, exercise F3 (write the reply to a friend whose family member is in treatment, under 150 words) is the best single instrument in the chapter. It is nearly impossible to complete well without having integrated the science, the evidence standard, and the human situation simultaneously. Grade tone as heavily as content.

Timing suggestion

Sections 9 and 6 are the ones to cut under time pressure. Do not cut 5 or 10.